The healthcare provider has ordered 1000 mL of 0.9% sodium chloride to be administered intravenously over 5 hours. The drop factor on the tubing is 15 drops/mL. How many milliliters per hour will you administer and how many drops per minute?

A. Metered-dose inhaler (MDI): MDIs deliver a specific dose of medication in aerosol form. They consist of a pressurized canister containing medication and a mouthpiece or mask for inhalation. Patients must coordinate inhalation with actuation to ensure proper medication delivery to the lungs.

B. Nebulizer: Nebulizers convert liquid medication into a fine mist that can be inhaled directly into the lungs. They are commonly used for patients who have difficulty using MDIs or require higher doses of medication. Nebulizers are often used in acute care settings or at home for patients with chronic respiratory conditions.

C. Hypodermic syringe: Hypodermic syringes are used for administering injections subcutaneously, intramuscularly, or intravenously. They are not used for inhalation medication administration.

D. Feeding tube syringe: Feeding tube syringes are used for administering liquid medications or enteral feeds through feeding tubes directly into the gastrointestinal tract. They are not used for inhalation medication administration.

E. Dry powder inhaler (DPI): DPIs deliver medication in powdered form, which is activated by the patient's inhalation. Unlike MDIs, DPIs do not require coordination between actuation and inhalation. Instead, patients inhale forcefully to disperse the medication into their lungs.

A. Diabetes: Diabetes is not typically a contraindication for decongestant use. However, patients with diabetes should be cautious with decongestants that contain sugar or other ingredients that may affect blood glucose levels.

B. Hypertension: Decongestants can cause vasoconstriction and increase blood pressure, which may exacerbate hypertension. Patients with hypertension should use decongestants cautiously and under the guidance of a healthcare provider.

C. Hyperthyroidism: While decongestants can stimulate the sympathetic nervous system and may exacerbate symptoms of hyperthyroidism such as tachycardia and palpitations, hyperthyroidism is not typically considered a contraindication for decongestant use. However, patients with hyperthyroidism should use decongestants cautiously and consult with their healthcare provider.

D. Heart disease: Decongestants can increase heart rate and blood pressure, potentially worsening symptoms in patients with heart disease such as coronary artery disease, heart failure, or arrhythmias. Patients with heart disease should use decongestants cautiously and consult with their healthcare provider before use.

E. Allergic rhinitis: Decongestants are often used to relieve nasal congestion associated with allergic rhinitis. While patients with allergic rhinitis may use decongestants, they should still use them cautiously and follow the recommended dosage instructions.